Review
doi: 10.1038/nri3902. Epub 2015 Oct 16.Immunological hallmarks of stromal cells in the tumour microenvironment
Affiliations
- PMID:26471778
- DOI: 10.1038/nri3902
Item in Clipboard
Review
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J Turley et al. Nat Rev Immunol.2015 Nov.
Display options
Format
Display options
Format
Abstract
A dynamic and mutualistic interaction between tumour cells and the surrounding stroma promotes the initiation, progression, metastasis and chemoresistance of solid tumours. Far less understood is the relationship between the stroma and tumour-infiltrating leukocytes; however, emerging evidence suggests that the stromal compartment can shape antitumour immunity and responsiveness to immunotherapy. Thus, there is growing interest in elucidating the immunomodulatory roles of the stroma that evolve within the tumour microenvironment. In this Review, we discuss the evidence that stromal determinants interact with leukocytes and influence antitumour immunity, with emphasis on the immunological attributes of stromal cells that may foster their protumorigenic function.
Similar articles
- Classification and biology of tumour associated stromal cells.Raffaghello L, Dazzi F.Raffaghello L, et al.Immunol Lett. 2015 Dec;168(2):175-82. doi: 10.1016/j.imlet.2015.06.016. Epub 2015 Jul 2.Immunol Lett. 2015.PMID:26145459Review.
- Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?Puré E, Lo A.Puré E, et al.Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011.Cancer Immunol Res. 2016.PMID:27036971Free PMC article.Review.
- The tumour microenvironment and implications for cancer immunotherapy.Petrulio CA, Kim-Schulze S, Kaufman HL.Petrulio CA, et al.Expert Opin Biol Ther. 2006 Jul;6(7):671-84. doi: 10.1517/14712598.6.7.671.Expert Opin Biol Ther. 2006.PMID:16805707Review.
- Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.Chung LW, Baseman A, Assikis V, Zhau HE.Chung LW, et al.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.J Urol. 2005.PMID:15592017Review.
- Metabolic reprogramming of the tumour microenvironment.Xing Y, Zhao S, Zhou BP, Mi J.Xing Y, et al.FEBS J. 2015 Oct;282(20):3892-8. doi: 10.1111/febs.13402. Epub 2015 Aug 25.FEBS J. 2015.PMID:26255648Review.
Cited by
- Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer.Zhang C, Yin W, Yuan LP, Xiao LJ, Yu J, Xiao WM, Luo G, Deng MM, Liu S, Lü MH.Zhang C, et al.Sci Rep. 2024 Oct 25;14(1):25426. doi: 10.1038/s41598-024-76565-w.Sci Rep. 2024.PMID:39455662Free PMC article.
- Obesity-Associated ECM Remodeling in Cancer Progression.Li J, Xu R.Li J, et al.Cancers (Basel). 2022 Nov 19;14(22):5684. doi: 10.3390/cancers14225684.Cancers (Basel). 2022.PMID:36428776Free PMC article.Review.
- Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.Huang B, Song BL, Xu C.Huang B, et al.Nat Metab. 2020 Feb;2(2):132-141. doi: 10.1038/s42255-020-0174-0. Epub 2020 Feb 10.Nat Metab. 2020.PMID:32694690Review.
- Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratiovs Platelet-to-lymphocyte ratio.Chen Y, Liao Y, Lam LM, He L, Tsang YS, Di YS, Liang ST, Xia Q.Chen Y, et al.Int J Med Sci. 2020 Jun 6;17(10):1449-1457. doi: 10.7150/ijms.46254. eCollection 2020.Int J Med Sci. 2020.PMID:32624701Free PMC article.
- Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy.Collado J, Boland L, Ahrendsen JT, Miska J, Lee-Chang C.Collado J, et al.Front Immunol. 2024 Feb 6;15:1336476. doi: 10.3389/fimmu.2024.1336476. eCollection 2024.Front Immunol. 2024.PMID:38380331Free PMC article.Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources